Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
23 avr. 2024 08h30 HE
|
Palisade Bio, Inc.
– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone in Palisade Bio's mission to...
Vytelle Expands Presence in Nebraska Region with the Opening of its 17th Global Laboratory, Ushering in a New Level of Accessibility to Hormone-Free in vitro Fertilization (IVF) for Cattle Producers
04 mars 2024 09h00 HE
|
Vytelle
Kearney, Nebraska, March 04, 2024 (GLOBE NEWSWIRE) -- Vytelle, the fastest-growing in vitro fertilization (IVF) company, proudly announces the opening of its 8th US-based and 17th global laboratory,...
Vytelle announces a strategic collaboration with Blocktrust Network to promote the value of feeder cattle on the basis of growth and efficiency bringing more transparency to this critical market segment in the beef supply chain
30 janv. 2024 10h58 HE
|
Vytelle
Lenexas, Kansas, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Vytelle, the fastest growing, independent IVF company and curator of the world’s largest feed efficiency database is pleased to announce a...
Ohmyhome and Webuy Announce Strategic Collaboration to Cross-Sell Products and Services Across Singapore
08 janv. 2024 08h30 HE
|
Ohmyhome Ltd.
Ohmyhome to offer Webuy’s grocery, travel and other services through its expansive network of homeownersWebuy to offer Ohmyhome’s property listing, renovation and other services through its community...
ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases
26 avr. 2022 03h00 HE
|
ViGeneron GmbH
The companies agree a follow-on collaboration to evaluate ViGeneron’s adeno-associated virus vectors (vgAAVs) for delivering Daiichi Sankyo’s novel therapeutic protein to treat prevalent eye diseases ...
ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target
06 avr. 2022 03h00 HE
|
ViGeneron GmbH
Regeneron receives access to ViGeneron’s vgAAV capsids for one inherited retinal disease target and an option for an exclusive license to develop and commercialize the gene therapy productViGeneron is...
Crinetics Pharmaceuticals and Sanwa Kagaku Kenkyusho Enter into Exclusive Licensing Agreement for the Development and Commercialization of Paltusotine in Japan
28 févr. 2022 06h00 HE
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO and NAGOYA, Japan, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and...
Rackspace Technology Expands Strategic Relationship with AWS
24 févr. 2022 11h00 HE
|
Rackspace Technology, Inc.
SAN ANTONIO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company is extending its Strategic Collaboration Agreement...
HUMBL and BLOCKS Announce Strategic Collaboration on Blockchain Initiatives
15 oct. 2021 15h43 HE
|
HUMBL, Inc.
San Diego, California, Oct. 15, 2021 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC Markets: HMBL), a consumer blockchain company working to simplify use cases across verticals like payments, ticketing and...
Meticulous Research® & AI Forum Announce Strategic Collaboration
28 avr. 2021 05h30 HE
|
Meticulous Market Research Pvt. Ltd.
London, April 28, 2021 (GLOBE NEWSWIRE) -- Meticulous Research® is pleased to announce a business partnership with AI Forum, a leading independent research and information source for the worldwide...